At the Semantic Technology and Business Conference in New York City last week, attendees got to hear a lot about how semantic technology is influencing various sectors, such as government (see our stories here and here) and media (see this article and this one). Another prominent one on display: pharmaceuticals.
Pharma, for example, was the driving use case for the update to Callimachus that focuses on helping users deal with data that’s external to the framework for data-driven applications, David Wood, CTO of Callimachus project sponsor 3 Round Stones, told The Semantic Web Blog at the event. (To learn more about the update, see our story here.)
A session on Tuesday last week saw Lee Feigenbaum, vp of marketing at Cambridge Semantics, which makes the Anzo express and Anzo Enterprise solutions, put forth a case for semantic tech as being key to data integration and interoperability in the sector, as well. “Can semantic web technologies break down enterprise data silos just as they break down document silos on the web?” he said. “The answer to the question is, “Of course.” Compared to the web, the data silo challenges of even the largest pharmaceuticals organization is relatively minor.”